Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Erector Spinae Plane Block with Low-Flow Anaesthesia in Laparoscopic Cholecystectomy

Official title: Evaluation of the Effects of Preoperative Erector Spinae Plane Block Combined With Low-Flow Anaesthesia on Postoperative Quality of Recovery and Opioid Consumption: A Prospective, Randomized, Controlled Study

Run by Taksim Egitim ve Arastirma Hastanesi · NCT07653490 · Data updated 2026-11-12

This trial tests whether a nerve block done before surgery plus very low-flow anesthesia reduces pain and opioid use after gallbladder removal.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment72 (estimated)
SponsorTaksim Egitim ve Arastirma Hastanesi
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedJune 18, 2026
Main results expectedMay 18, 2027
Study endsJune 18, 2027
Registry record updatedJune 23, 2026
Trial IDNCT07653490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with ASA I-II undergoing elective laparoscopic cholecystectomy, BMI < 35 kg/m2, and able to consent.

Probably not a fit

Patients with contraindications to regional anesthesia or who experience inadequate block may not experience pain relief or improved recovery.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized trial, patients undergoing elective laparoscopic cholecystectomy receive an ultrasound-guided erector spinae plane block combined with low-flow anesthesia and are compared to standard anesthesia care. The study looks at postoperative recovery quality, pain scores, analgesic needs, and perioperative outcomes using QoR-15 as a primary measure. The ESP block targets thoracic levels to provide somatic and visceral analgesia, potentially enhancing recovery and reducing opioid requirements. The design reflects a multimodal approach to postoperative pain management in a common surgical procedure.

Why it matters

Potential benefit: If successful, participants may experience better postoperative recovery and less opioid use after laparoscopic cholecystectomy.

How similar studies have gone: Prior studies suggest regional blocks can reduce pain and opioid needs, but results vary by technique and surgery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18-65 years
* ASA physical status I-II
* Body mass index (BMI) \<35 kg/m²
* Scheduled for elective laparoscopic cholecystectomy
* Ability to provide written informed consent

Exclusion Criteria:

* Coagulopathy or bleeding disorders
* Allergy to local anaesthetic agents
* Infection at the block application site
* Neurological or psychiatric disorders
* Communication difficulties
* Chronic opioid or analgesic use
* Reoperation cases
* Acute cholecystitis
* Conversion to open surgery
* Inadequate dermatomal block after ESPB
* Severe intraoperative hemodynamic instability
* Intraoperative blood loss ≥250 mL
* Development of allergic reactions or major complications during follow-up

Where it's running

  • Taksim Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Leyla SIVACIGIL, MD — Taksim Training and Research Hospital
  • Study coordinator: Leyla Sivacigil, MD
  • Email: veralleyla@hotmail.com
  • Phone: 90 5065983478

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.